The Spectra Optia Apheresis System (Terumo BCT) is an apheresis and cell collection platform which can be used in the treatment of sickle cell disease. The purpose of this evaluation is to assess the ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader ...
Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths [1, 2] and taking more lives than cancer [3]. This is more than ...
In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM), Terumo Blood and Cell Technologies (Terumo BCT), announced that its Spectra ...
The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity. The Food and Drug Administration (FDA) has issued an Emergency Use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback